Carregant...
DHE-Induced Peripheral Arterial Vasospasm in Primary Raynaud Phenomenon: Case Report
Dihydroergotamine (DHE) is primarily a serotonin 5HT1B and 5HT1D receptor agonist used for acute migraine treatment. It is associated with acute vasoconstriction mediated through the 5HT1B receptor and is contraindicated in patients with history of cardiac disease and peripheral vascular disease. We...
Guardat en:
| Publicat a: | Neurohospitalist |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
SAGE Publications
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6429678/ https://ncbi.nlm.nih.gov/pubmed/30915191 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1941874418797764 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|